Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All PPI studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchPPIsPPIs (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors

Almario et al., American Journal of Gastroenterology, doi:10.14309/ajg.0000000000000798
Aug 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Case, combined -179% Improvement Relative Risk Case, twice daily or less -267% Case, once daily -115% PPIs for COVID-19  Almario et al.  Prophylaxis Do PPIs reduce COVID-19 infections? Retrospective 51,973 patients in the USA (May - June 2020) More cases with PPIs (p=0.00014) c19early.org Almario et al., American J. Gastroente.., Aug 2020 FavorsPPI Favorscontrol 0 0.5 1 1.5 2+
PPIs for COVID-19
1st treatment shown to increase risk in September 2020
 
*, now with p = 0.00000031 from 37 studies.
* From meta analysis with ≥3 studies.
4,700+ studies for 94 treatments. c19early.org
Survey of 53,130 individuals with a history of GI symptoms showing increased risk of COVID-19 positivity with proton pump inhibitor (PPI) use, especially twice-daily PPI use. There was a dose-response relationship between PPI use and COVID-19 risk. Those taking PPIs twice daily had 3.67 times higher odds of testing positive compared to those not taking PPIs. The authors hypothesize that PPI-induced hypochlorhydria may impair the body's defense against ingested pathogens like SARS-CoV-2.
risk of case, 178.5% higher, RR 2.79, p < 0.001, treatment 7,387, control 44,586, adjusted per study, combined.
risk of case, 267.0% higher, OR 3.67, p < 0.001, treatment 1,157, control 44,586, adjusted per study, twice daily or less, multivariable, RR approximated with OR.
risk of case, 115.0% higher, OR 2.15, p < 0.001, treatment 7,387, control 44,586, adjusted per study, once daily, multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Almario et al., 25 Aug 2020, retrospective, USA, peer-reviewed, 3 authors, study period 3 May, 2020 - 24 June, 2020.
This PaperPPIsAll
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors
MD, MSHPM Christopher V Almario, MD William D Chey, MD, MSHS. Brennan M R Spiegel
American Journal of Gastroenterology, doi:10.14309/ajg.0000000000000798
INTRODUCTION: Proton pump inhibitors (PPIs) increase the risk for enteric infections that is likely related to PPI-induced hypochlorhydria. Although the impact of acid suppression on severe acute respiratory syndrome coronavirus 2 is unknown thus far, previous data revealed that pH £3 impairs the infectivity of the similar severe acute respiratory syndrome coronavirus 1. Thus, we aimed to determine whether use of PPIs increases the odds for acquiring coronavirus disease 2019 (COVID-19) among community-dwelling Americans. METHODS: From May 3 to June 24, 2020, we performed an online survey described to participating adults as a "national health survey." A multivariable logistic regression was performed on reporting a positive COVID-19 test to adjust for a wide range of confounding factors and to calculate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). RESULTS: Of 53,130 participants, 3,386 (6.4%) reported a positive COVID-19 test. In regression analysis, individuals using PPIs up to once daily (aOR 2.15; 95% CI, 1.90-2.44) or twice daily (aOR 3.67; 95% CI, 2.93-4.60) had significantly increased odds for reporting a positive COVID-19 test when compared with those not taking PPIs. Individuals taking histamine-2 receptor antagonists were not at elevated risk. DISCUSSION: We found evidence of an independent, dose-response relationship between the use of antisecretory medications and COVID-19 positivity; individuals taking PPIs twice daily have higher odds for reporting a positive test when compared with those using lower-dose PPIs up to once daily, and those taking the less potent histamine-2 receptor antagonists are not at increased risk. These findings emphasize good clinical practice that PPIs should only be used when indicated at the lowest effective dose, such as the approved once-daily label dosage of over-the-counter and prescription PPIs. Further studies examining the association between PPIs and COVID-19 are needed.
CONFLICTS OF INTEREST Guarantor of the article: Brennan M.R. Spiegel, MD, MSHS. Specific author contributions: C.V.A.; W.D.C.; B.M.R.S.: substantial contributions to the conception and design of the work; acquisition, analysis, and interpretation of data for the work; drafting the work and revising it critically for important intellectual content; final approval of the version to be published. Financial support: The data used in this analysis were derived from a larger study evaluating gastrointestinal symptoms in America funded by a grant from Ironwood Pharmaceuticals. In response to the COVID-19 pandemic and before launching the parent study, we added additional questions regarding self-reported COVID-19 testing and related symptoms. Separate funding was not received for the analyses presented in this report.
References
Anyane-Yeboa, Sato, Sakuraba, Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America, J Intern Med
Azar, Shen, Romanelli, Disparities in outcomes among COVID-19 patients in a large health care system in California, Health Aff (Millwood)
Bavishi, Dupont, Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection, Aliment Pharmacol Ther
Bosman, Mervosh, As Virus Surges, Younger People Account for "Disturbing" Number of Cases
Bryant, Szejda, Parekh, A survey of consumer perceptions of plant-based and clean meat in the USA, India, and China, Front Sustain Food Syst
Burdsall, Flores, Krueger, Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities, J Am Med Dir Assoc
Chang, Grotts, Tseng, Time trends in physician visits for gastroesophageal reflux disease before and after the Rx-to-OTC switch of proton pump inhibitors, J Clin Pharmacol
Chen, Lou, Bai, COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests, Am J Gastroenterol
Cheung, Hung, Chan, Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: Systematic review and meta-analysis, Gastroenterology
Chey, Mody, Wu, Treatment patterns and symptom control in patients with GERD: US community-based survey, Curr Med Res Opin
Dahly, Elia, Johansen, A Letter of Concern Regarding Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors by Almario, Chey, and Spiegel
Darnell, Subbarao, Feinstone, Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV, J Virol Methods
Daughton, Wastewater surveillance for population-wide Covid-19: The present and future, Sci Total Environ
Dhar, Mohanty, Gut microbiota and Covid-19-possible link and implications, Virus Res
Eid, Boueiz, Paranji, Patterns and predictors of proton pump inhibitor overuse among academic and non-academic hospitalists, Intern Med
Foladori, Cutrupi, Segata, SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review, Sci Total Environ
Garg, Kim, Whitaker, Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 States, March 1-30, 2020, MMWR Morb Mortal Wkly Rep
George, Korc, Ross, Appropriate proton pump inhibitor use among older adults: A retrospective chart review, Am J Geriatr Pharmacother
Glew, Rentler, Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients, J Am Med Dir Assoc
Gliklich, Maurer, Bergmark, Patterns of texting and driving in a US national survey of millennial parents vs older parents, JAMA Pediatr
Hamming, Timens, Bulthuis, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol
Hooper, Nápoles, Ej, COVID-19 and racial/ ethnic disparities, JAMA
Horner, T9ZGcT7ozdw&cid54D5E0A2E1FAED8C5&id54D5E0 A2E1FAED8C5%21574&parId54D5E0A2E1FAED8C5% 21252&o5OneUp)
Inadomi, Jamal, Murata, Step-down management of gastroesophageal reflux disease, Gastroenterology
Inadomi, Mcintyre, Bernard, Step-down from multiple-to single-dose proton pump inhibitors (PPIs): A prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs, Am J Gastroenterol
Kanno, Matsuki, Oka, Gastric acid reduction leads to an alteration in lower intestinal microflora, Biochem Biophys Res Commun
Kelly, Dillane, Patchett, The inappropriate prescription of oral proton pump inhibitors in the hospital setting: A prospective crosssectional study, Dig Dis Sci
Kochhar, Hispanic Women, Immigrants, Young Adults, Those with Less Education Hit Hardest by COVID-19 Job Losses
Krogstad, Gozalez-Barrera, Noe-Bustamante, Latinos Among Hardest Hit by Pay Cuts, Job Losses Due to Coronavirus
Lamers, Beumer, Van Der Vaart, SARS-CoV-2 productively infects human gut enterocytes, Science
Leonard, Marshall, Moayyedi, Systematic review of the risk of enteric infection in patients taking acid suppression, Am J Gastroenterol
Leri, Ayzenberg, Voyce, Four-year trends of inappropriate proton pump inhibitor use after hospital discharge, South Med J
Lo, Chan, Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: A meta-analysis, Clin Gastroenterol Hepatol
Menni, Valdes, Freidin, Real-time tracking of selfreported symptoms to predict potential COVID-19, Nat Med
Metaxas, Bain, Review of proton pump inhibitor overuse in the US Veteran population, J Pharm Technol
Moayyedi, Eikelboom, Bosch, Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin, Gastroenterology
Nabi, Siddique, Khan, Detecting viral outbreaks in future using enhanced environmental surveillance, Environ Res
Near, None
Palsson, Whitehead, Van Tilburg, Development and validation of the Rome IV diagnostic questionnaire for adults, Gastroenterology
Parish, Faubion, Weinberg, The MATE survey: Men's perceptions and attitudes towards menopause and their role in partners' menopausal transition, Menopause
Peccia, Zulli, Brackney, SARS-CoV-2 RNA concentrations in primary municipal sewage sludge as a leading indicator of COVID-19 outbreak dynamics, medRxiv
Robin, Keller, Zwiener, Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria, J Pediatr
Seto, Jeraldo, Orenstein, Prolonged use of a proton pump inhibitor reduces microbial diversity: Implications for Clostridium difficile susceptibility, Microbiome
Sood, Simon, Ebner, Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10-11, 2020, JAMA
Spiegel, Hays, Bolus, Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales, Am J Gastroenterol
Stelzig, Canepa-Escaro, Schiliro, Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells, Am J Physiol Lung Cell Mol Physiol
Stephens, Foley, Miller, The effects of health disparities on perceptions about lung cancer screening (LCS): Survey results of a patient sample, Lung
Stokes, Zambrano, Anderson, Coronavirus disease 2019 case surveillance -United States, January 22-May 30, 2020, MMWR Morb Mortal Wkly Rep
Sultan, Altayar, Siddique, AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19, Gastroenterology
Targownik, Metge, Roos, The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use, Am J Gastroenterol
Trottein, Sokol, Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection, Cell Rep
Uno, Why does SARS-CoV-2 invade the gastrointestinal epithelium?, Gastroenterology
Vaezi, Yang, Howden, Complications of proton pump inhibitor therapy, Gastroenterology
Van Tilburg, Hyman, Walker, Prevalence of functional gastrointestinal disorders in infants and toddlers, J Pediatr
Vardavas, Nikitara, COVID-19 and smoking: A systematic review of the evidence, Tob Induc Dis
Vilcu, Sabatte, Blanchon, Association between acute gastroenteritis and continuous use of proton pump inhibitors during winter periods of highest circulation of enteric viruses, JAMA Netw Open
Wadhera, Wadhera, Gaba, Variation in COVID-19 hospitalizations and deaths across New York City boroughs, JAMA
Wang, Xu, Gao, Detection of SARS-CoV-2 in different types of clinical specimens, JAMA
Wilkins, Mapes, Jerome, Understanding what information is valued by research participants, and why, Health Aff
Wu, Guo, Tang, Prolonged presence of SARS-CoV-2 viral RNA in faecal samples, Lancet Gastroenterol Hepatol
Xiao, Sun, Xu, Infectious SARS-CoV-2 in feces of patient with severe COVID-19, Emerg Infect Dis
Xiao, Tang, Zheng, Evidence for gastrointestinal infection of SARS-CoV-2, Gastroenterology
Yeo, Kaushal, Yeo, Enteric involvement of coronaviruses: Is faecaloral transmission of SARS-CoV-2 possible?, Lancet Gastroenterol Hepatol
Zhang, Yang, Ni, A meta-analysis and systematic review of the efficacy of twice daily PPIs versus once daily for treatment of gastroesophageal reflux disease, Gastroenterol Res Pract
Zhou, Li, Zhao, Human intestinal tract serves as an alternative infection route for Middle East Respiratory Syndrome coronavirus, Sci Adv
{ 'indexed': {'date-parts': [[2024, 7, 20]], 'date-time': '2024-07-20T19:32:25Z', 'timestamp': 1721503945298}, 'reference-count': 59, 'publisher': 'Ovid Technologies (Wolters Kluwer Health)', 'issue': '10', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020, 10]]}, 'abstract': '<jats:sec>\n' ' <jats:title>INTRODUCTION:</jats:title>\n' ' <jats:p>Proton pump inhibitors (PPIs) increase the risk for enteric infections ' 'that is likely related to PPI-induced hypochlorhydria. Although the impact of acid ' 'suppression on severe acute respiratory syndrome coronavirus 2 is unknown thus far, previous ' 'data revealed that pH ≤3 impairs the infectivity of the similar severe acute respiratory ' 'syndrome coronavirus 1. Thus, we aimed to determine whether use of PPIs increases the odds ' 'for acquiring coronavirus disease 2019 (COVID-19) among community-dwelling ' 'Americans.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>METHODS:</jats:title>\n' ' <jats:p>From May 3 to June 24, 2020, we performed an online survey described to ' 'participating adults as a “national health survey.” A multivariable logistic regression was ' 'performed on reporting a positive COVID-19 test to adjust for a wide range of confounding ' 'factors and to calculate adjusted odds ratios (aORs) and 95% confidence intervals ' '(CIs).</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>RESULTS:</jats:title>\n' ' <jats:p>Of 53,130 participants, 3,386 (6.4%) reported a positive COVID-19 test. ' 'In regression analysis, individuals using PPIs up to once daily (aOR 2.15; 95% CI, 1.90–2.44) ' 'or twice daily (aOR 3.67; 95% CI, 2.93–4.60) had significantly increased odds for reporting a ' 'positive COVID-19 test when compared with those not taking PPIs. Individuals taking ' 'histamine-2 receptor antagonists were not at elevated risk.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>DISCUSSION:</jats:title>\n' ' <jats:p>We found evidence of an independent, dose-response relationship between ' 'the use of antisecretory medications and COVID-19 positivity; individuals taking PPIs twice ' 'daily have higher odds for reporting a positive test when compared with those using ' 'lower-dose PPIs up to once daily, and those taking the less potent histamine-2 receptor ' 'antagonists are not at increased risk. These findings emphasize good clinical practice that ' 'PPIs should only be used when indicated at the lowest effective dose, such as the approved ' 'once-daily label dosage of over-the-counter and prescription PPIs. Further studies examining ' 'the association between PPIs and COVID-19 are needed.</jats:p>\n' ' </jats:sec>', 'DOI': '10.14309/ajg.0000000000000798', 'type': 'journal-article', 'created': {'date-parts': [[2020, 8, 26]], 'date-time': '2020-08-26T21:12:37Z', 'timestamp': 1598476357000}, 'page': '1707-1715', 'source': 'Crossref', 'is-referenced-by-count': 157, 'title': 'Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors', 'prefix': '10.14309', 'volume': '115', 'author': [ { 'given': 'Christopher V.', 'family': 'Almario', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Medicine, Cedars-Sinai Medical Center, Los ' 'Angeles, California, USA;'}, { 'name': 'Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai ' 'Medical Center, Los Angeles, California, USA;'}, { 'name': 'Cedars-Sinai Center for Outcomes Research and Education ' '(CS-CORE), Los Angeles, California, USA;'}, { 'name': 'Division of Health Services Research, Cedars-Sinai Medical ' 'Center, Los Angeles, California, USA;'}, { 'name': 'Division of Informatics, Cedars-Sinai Medical Center, Los ' 'Angeles, California, USA;'}]}, { 'given': 'William D.', 'family': 'Chey', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Medicine, Michigan Medicine, Ann Arbor, Michigan, ' 'USA;'}, { 'name': 'Division of Gastroenterology, Michigan Medicine, Ann Arbor, ' 'Michigan, USA;'}]}, { 'given': 'Brennan M.R.', 'family': 'Spiegel', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Medicine, Cedars-Sinai Medical Center, Los ' 'Angeles, California, USA;'}, { 'name': 'Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai ' 'Medical Center, Los Angeles, California, USA;'}, { 'name': 'Cedars-Sinai Center for Outcomes Research and Education ' '(CS-CORE), Los Angeles, California, USA;'}, { 'name': 'Division of Health Services Research, Cedars-Sinai Medical ' 'Center, Los Angeles, California, USA;'}, { 'name': 'Department of Health Policy and Management, UCLA Fielding School ' 'of Public Health, Los Angeles, California, USA.'}]}], 'member': '276', 'published-online': {'date-parts': [[2020, 8, 25]]}, 'reference': [ { 'key': 'R1-20230812', 'doi-asserted-by': 'crossref', 'first-page': '35', 'DOI': '10.1053/j.gastro.2017.04.047', 'article-title': 'Complications of proton pump inhibitor therapy', 'volume': '153', 'author': 'Vaezi', 'year': '2017', 'journal-title': 'Gastroenterology'}, { 'key': 'R2-20230812', 'doi-asserted-by': 'crossref', 'first-page': '682', 'DOI': '10.1053/j.gastro.2019.05.056', 'article-title': 'Safety of proton pump inhibitors based on a large, multi-year, ' 'randomized trial of patients receiving rivaroxaban or aspirin', 'volume': '157', 'author': 'Moayyedi', 'year': '2019', 'journal-title': 'Gastroenterology'}, { 'key': 'R3-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1269', 'DOI': '10.1111/j.1365-2036.2011.04874.x', 'article-title': 'Systematic review: The use of proton pump inhibitors and increased ' 'susceptibility to enteric infection', 'volume': '34', 'author': 'Bavishi', 'year': '2011', 'journal-title': 'Aliment Pharmacol Ther'}, { 'key': 'R4-20230812', 'doi-asserted-by': 'crossref', 'first-page': '2047', 'DOI': '10.1111/j.1572-0241.2007.01275.x', 'article-title': 'Systematic review of the risk of enteric infection in patients taking ' 'acid suppression', 'volume': '102', 'author': 'Leonard', 'year': '2007', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R5-20230812', 'doi-asserted-by': 'crossref', 'first-page': '483', 'DOI': '10.1016/j.cgh.2012.12.011', 'article-title': 'Proton pump inhibitor use and the risk of small intestinal bacterial ' 'overgrowth: A meta-analysis', 'volume': '11', 'author': 'Lo', 'year': '2013', 'journal-title': 'Clin Gastroenterol Hepatol'}, { 'key': 'R6-20230812', 'doi-asserted-by': 'crossref', 'first-page': 'e1916205', 'DOI': '10.1001/jamanetworkopen.2019.16205', 'article-title': 'Association between acute gastroenteritis and continuous use of proton ' 'pump inhibitors during winter periods of highest circulation of enteric ' 'viruses', 'volume': '2', 'author': 'Vilcu', 'year': '2019', 'journal-title': 'JAMA Netw Open'}, { 'key': 'R7-20230812', 'doi-asserted-by': 'crossref', 'first-page': '666', 'DOI': '10.1016/j.bbrc.2009.02.109', 'article-title': 'Gastric acid reduction leads to an alteration in lower intestinal ' 'microflora', 'volume': '381', 'author': 'Kanno', 'year': '2009', 'journal-title': 'Biochem Biophys Res Commun'}, { 'key': 'R8-20230812', 'doi-asserted-by': 'crossref', 'first-page': '42', 'DOI': '10.1186/2049-2618-2-42', 'article-title': 'Prolonged use of a proton pump inhibitor reduces microbial diversity: ' 'Implications for Clostridium difficile susceptibility', 'volume': '2', 'author': 'Seto', 'year': '2014', 'journal-title': 'Microbiome'}, { 'key': 'R9-20230812', 'doi-asserted-by': 'crossref', 'first-page': '85', 'DOI': '10.1016/j.jviromet.2004.06.006', 'article-title': 'Inactivation of the coronavirus that induces severe acute respiratory ' 'syndrome, SARS-CoV', 'volume': '121', 'author': 'Darnell', 'year': '2004', 'journal-title': 'J Virol Methods'}, { 'key': 'R10-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1831', 'DOI': '10.1053/j.gastro.2020.02.055', 'article-title': 'Evidence for gastrointestinal infection of SARS-CoV-2', 'volume': '158', 'author': 'Xiao', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R11-20230812', 'doi-asserted-by': 'crossref', 'first-page': '107915', 'DOI': '10.1016/j.celrep.2020.107915', 'article-title': 'Potential causes and consequences of gastrointestinal disorders during ' 'a SARS-CoV-2 infection', 'volume': '32', 'author': 'Trottein', 'year': '2020', 'journal-title': 'Cell Rep'}, { 'key': 'R12-20230812', 'doi-asserted-by': 'crossref', 'first-page': '631', 'DOI': '10.1002/path.1570', 'article-title': 'Tissue distribution of ACE2 protein, the functional receptor for SARS ' 'coronavirus. A first step in understanding SARS pathogenesis', 'volume': '203', 'author': 'Hamming', 'year': '2004', 'journal-title': 'J Pathol'}, { 'key': 'R13-20230812', 'doi-asserted-by': 'crossref', 'first-page': '50', 'DOI': '10.1126/science.abc1669', 'article-title': 'SARS-CoV-2 productively infects human gut enterocytes', 'volume': '369', 'author': 'Lamers', 'year': '2020', 'journal-title': 'Science'}, { 'key': 'R14-20230812', 'doi-asserted-by': 'crossref', 'first-page': '320', 'DOI': '10.1053/j.gastro.2020.05.001', 'article-title': 'AGA Institute rapid review of the GI and liver manifestations of ' 'COVID-19, meta-analysis of international data, and recommendations for ' 'the consultative management of patients with COVID-19', 'volume': '159', 'author': 'Sultan', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R15-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1920', 'DOI': '10.3201/eid2608.200681', 'article-title': 'Infectious SARS-CoV-2 in feces of patient with severe COVID-19', 'volume': '26', 'author': 'Xiao', 'year': '2020', 'journal-title': 'Emerg Infect Dis'}, { 'key': 'R16-20230812', 'first-page': '1843', 'article-title': 'Detection of SARS-CoV-2 in different types of clinical specimens', 'volume': '323', 'author': 'Wang', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'R17-20230812', 'doi-asserted-by': 'crossref', 'first-page': '81', 'DOI': '10.1053/j.gastro.2020.03.065', 'article-title': 'Gastrointestinal manifestations of SARS-CoV-2 infection and virus load ' 'in fecal samples from a Hong Kong cohort: Systematic review and ' 'meta-analysis', 'volume': '159', 'author': 'Cheung', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R18-20230812', 'doi-asserted-by': 'crossref', 'first-page': '790', 'DOI': '10.14309/ajg.0000000000000610', 'article-title': 'COVID-19 disease with positive fecal and negative pharyngeal and sputum ' 'viral tests', 'volume': '115', 'author': 'Chen', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R19-20230812', 'doi-asserted-by': 'crossref', 'first-page': '140444', 'DOI': '10.1016/j.scitotenv.2020.140444', 'article-title': 'SARS-CoV-2 from faeces to wastewater treatment: What do we know? A ' 'review', 'volume': '743', 'author': 'Foladori', 'year': '2020', 'journal-title': 'Sci Total Environ'}, { 'key': 'R20-20230812', 'doi-asserted-by': 'crossref', 'first-page': '109731', 'DOI': '10.1016/j.envres.2020.109731', 'article-title': 'Detecting viral outbreaks in future using enhanced environmental ' 'surveillance', 'volume': '188', 'author': 'Nabi', 'year': '2020', 'journal-title': 'Environ Res'}, { 'key': 'R21-20230812', 'doi-asserted-by': 'crossref', 'first-page': '139631', 'DOI': '10.1016/j.scitotenv.2020.139631', 'article-title': 'Wastewater surveillance for population-wide Covid-19: The present and ' 'future', 'volume': '736', 'author': 'Daughton', 'year': '2020', 'journal-title': 'Sci Total Environ'}, { 'key': 'R22-20230812', 'article-title': 'SARS-CoV-2 RNA concentrations in primary municipal sewage sludge as a ' 'leading indicator of COVID-19 outbreak dynamics', 'author': 'Peccia', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': 'R23-20230812', 'doi-asserted-by': 'crossref', 'first-page': '335', 'DOI': '10.1016/S2468-1253(20)30048-0', 'article-title': 'Enteric involvement of coronaviruses: Is faecal-oral transmission of ' 'SARS-CoV-2 possible?', 'volume': '5', 'author': 'Yeo', 'year': '2020', 'journal-title': 'Lancet Gastroenterol Hepatol'}, { 'key': 'R24-20230812', 'doi-asserted-by': 'crossref', 'first-page': '434', 'DOI': '10.1016/S2468-1253(20)30083-2', 'article-title': 'Prolonged presence of SARS-CoV-2 viral RNA in faecal samples', 'volume': '5', 'author': 'Wu', 'year': '2020', 'journal-title': 'Lancet Gastroenterol Hepatol'}, { 'key': 'R25-20230812', 'doi-asserted-by': 'crossref', 'first-page': '198018', 'DOI': '10.1016/j.virusres.2020.198018', 'article-title': 'Gut microbiota and Covid-19- possible link and implications', 'volume': '285', 'author': 'Dhar', 'year': '2020', 'journal-title': 'Virus Res'}, { 'key': 'R26-20230812', 'doi-asserted-by': 'crossref', 'first-page': 'eaao4966', 'DOI': '10.1126/sciadv.aao4966', 'article-title': 'Human intestinal tract serves as an alternative infection route for ' 'Middle East Respiratory Syndrome coronavirus', 'volume': '3', 'author': 'Zhou', 'year': '2017', 'journal-title': 'Sci Adv'}, { 'key': 'R27-20230812', 'doi-asserted-by': 'crossref', 'DOI': '10.1053/j.gastro.2020.04.006', 'article-title': 'Why does SARS-CoV-2 invade the gastrointestinal epithelium?', 'author': 'Uno', 'year': '2020', 'journal-title': 'Gastroenterology'}, { 'key': 'R29-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1481', 'DOI': '10.1053/j.gastro.2016.02.014', 'article-title': 'Development and validation of the Rome IV diagnostic questionnaire for ' 'adults', 'volume': '150', 'author': 'Palsson', 'year': '2016', 'journal-title': 'Gastroenterology'}, { 'key': 'R30-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1110', 'DOI': '10.1097/GME.0000000000001373', 'article-title': "The MATE survey: Men's perceptions and attitudes towards menopause and " "their role in partners' menopausal transition", 'volume': '26', 'author': 'Parish', 'year': '2019', 'journal-title': 'Menopause'}, { 'key': 'R31-20230812', 'doi-asserted-by': 'crossref', 'first-page': '134', 'DOI': '10.1016/j.jpeds.2017.12.012', 'article-title': 'Prevalence of pediatric functional gastrointestinal disorders utilizing ' 'the Rome IV criteria', 'volume': '195', 'author': 'Robin', 'year': '2018', 'journal-title': 'J Pediatr'}, { 'key': 'R32-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1804', 'DOI': '10.1038/ajg.2014.237', 'article-title': 'Development of the NIH Patient-Reported Outcomes Measurement ' 'Information System (PROMIS) gastrointestinal symptom scales', 'volume': '109', 'author': 'Spiegel', 'year': '2014', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R33-20230812', 'doi-asserted-by': 'crossref', 'first-page': '684', 'DOI': '10.1016/j.jpeds.2014.11.039', 'article-title': 'Prevalence of functional gastrointestinal disorders in infants and ' 'toddlers', 'volume': '166', 'author': 'Van Tilburg', 'year': '2015', 'journal-title': 'J Pediatr'}, { 'key': 'R34-20230812', 'doi-asserted-by': 'crossref', 'first-page': '399', 'DOI': '10.1377/hlthaff.2018.05046', 'article-title': 'Understanding what information is valued by research participants, and ' 'why', 'volume': '38', 'author': 'Wilkins', 'year': '2019', 'journal-title': 'Health Aff'}, { 'key': 'R35-20230812', 'doi-asserted-by': 'crossref', 'first-page': '11', 'DOI': '10.3389/fsufs.2019.00011', 'article-title': 'A survey of consumer perceptions of plant-based and clean meat in the ' 'USA, India, and China', 'volume': '3', 'author': 'Bryant', 'year': '2019', 'journal-title': 'Front Sustain Food Syst'}, { 'key': 'R36-20230812', 'doi-asserted-by': 'crossref', 'first-page': '689', 'DOI': '10.1001/jamapediatrics.2019.0830', 'article-title': 'Patterns of texting and driving in a US national survey of millennial ' 'parents vs older parents', 'volume': '173', 'author': 'Gliklich', 'year': '2019', 'journal-title': 'JAMA Pediatr'}, { 'key': 'R37-20230812', 'doi-asserted-by': 'crossref', 'first-page': '735', 'DOI': '10.1007/s00408-019-00281-w', 'article-title': 'The effects of health disparities on perceptions about lung cancer ' 'screening (LCS): Survey results of a patient sample', 'volume': '197', 'author': 'Stephens', 'year': '2019', 'journal-title': 'Lung'}, { 'key': 'R38-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1253', 'DOI': '10.1377/hlthaff.2020.00598', 'article-title': 'Disparities in outcomes among COVID-19 patients in a large health care ' 'system in California', 'volume': '39', 'author': 'Azar', 'year': '2020', 'journal-title': 'Health Aff (Millwood)'}, { 'key': 'R39-20230812', 'doi-asserted-by': 'crossref', 'first-page': 'L1280', 'DOI': '10.1152/ajplung.00153.2020', 'article-title': 'Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in ' 'differentiated airway epithelial cells', 'volume': '318', 'author': 'Stelzig', 'year': '2020', 'journal-title': 'Am J Physiol Lung Cell Mol Physiol'}, { 'key': 'R40-20230812', 'doi-asserted-by': 'crossref', 'first-page': '20', 'DOI': '10.18332/tid/119324', 'article-title': 'COVID-19 and smoking: A systematic review of the evidence', 'volume': '18', 'author': 'Vardavas', 'year': '2020', 'journal-title': 'Tob Induc Dis'}, { 'key': 'R41-20230812', 'doi-asserted-by': 'crossref', 'first-page': '2192', 'DOI': '10.1001/jama.2020.7197', 'article-title': 'Variation in COVID-19 hospitalizations and deaths across New York City ' 'boroughs', 'volume': '323', 'author': 'Wadhera', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'R42-20230812', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jama.2020.8598', 'article-title': 'COVID-19 and racial/ethnic disparities', 'author': 'Webb Hooper', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'R43-20230812', 'doi-asserted-by': 'crossref', 'first-page': '2425', 'DOI': '10.1001/jama.2020.8279', 'article-title': 'Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los ' 'Angeles County, California, on April 10-11, 2020', 'volume': '323', 'author': 'Sood', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'R44-20230812', 'doi-asserted-by': 'crossref', 'DOI': '10.1111/joim.13117', 'article-title': 'Racial disparities in COVID-19 deaths reveal harsh truths about ' 'structural inequality in America', 'author': 'Anyane-Yeboa', 'year': '2020', 'journal-title': 'J Intern Med'}, { 'key': 'R47-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1869', 'DOI': '10.1185/03007990903035745', 'article-title': 'Treatment patterns and symptom control in patients with GERD: US ' 'community-based survey', 'volume': '25', 'author': 'Chey', 'year': '2009', 'journal-title': 'Curr Med Res Opin'}, { 'key': 'R48-20230812', 'doi-asserted-by': 'crossref', 'first-page': '942', 'DOI': '10.1111/j.1572-0241.2007.01106.x', 'article-title': 'The prevalence of and the clinical and demographic characteristics ' 'associated with high-intensity proton pump inhibitor use', 'volume': '102', 'author': 'Targownik', 'year': '2007', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R49-20230812', 'doi-asserted-by': 'crossref', 'first-page': '9865963', 'DOI': '10.1155/2017/9865963', 'article-title': 'A meta-analysis and systematic review of the efficacy of twice daily ' 'PPIs versus once daily for treatment of gastroesophageal reflux disease', 'volume': '2017', 'author': 'Zhang', 'year': '2017', 'journal-title': 'Gastroenterol Res Pract'}, { 'key': 'R50-20230812', 'doi-asserted-by': 'crossref', 'first-page': '2561', 'DOI': '10.2169/internalmedicine.49.4064', 'article-title': 'Patterns and predictors of proton pump inhibitor overuse among academic ' 'and non-academic hospitalists', 'volume': '49', 'author': 'Eid', 'year': '2010', 'journal-title': 'Intern Med'}, { 'key': 'R51-20230812', 'doi-asserted-by': 'crossref', 'first-page': '249', 'DOI': '10.1016/j.amjopharm.2008.12.001', 'article-title': 'Appropriate proton pump inhibitor use among older adults: A ' 'retrospective chart review', 'volume': '6', 'author': 'George', 'year': '2008', 'journal-title': 'Am J Geriatr Pharmacother'}, { 'key': 'R52-20230812', 'doi-asserted-by': 'crossref', 'first-page': '607', 'DOI': '10.1016/j.jamda.2007.07.001', 'article-title': 'Use of proton pump inhibitors and other acid suppressive medications in ' 'newly admitted nursing facility patients', 'volume': '8', 'author': 'Glew', 'year': '2007', 'journal-title': 'J Am Med Dir Assoc'}, { 'key': 'R53-20230812', 'doi-asserted-by': 'crossref', 'first-page': '2280', 'DOI': '10.1007/s10620-015-3642-8', 'article-title': 'The inappropriate prescription of oral proton pump inhibitors in the ' 'hospital setting: A prospective cross-sectional study', 'volume': '60', 'author': 'Kelly', 'year': '2015', 'journal-title': 'Dig Dis Sci'}, { 'key': 'R54-20230812', 'doi-asserted-by': 'crossref', 'first-page': '270', 'DOI': '10.1097/SMJ.0b013e31828db01f', 'article-title': 'Four-year trends of inappropriate proton pump inhibitor use after ' 'hospital discharge', 'volume': '106', 'author': 'Leri', 'year': '2013', 'journal-title': 'South Med J'}, { 'key': 'R55-20230812', 'doi-asserted-by': 'crossref', 'first-page': '167', 'DOI': '10.1177/8755122515575177', 'article-title': 'Review of proton pump inhibitor overuse in the US Veteran population', 'volume': '31', 'author': 'Metaxas', 'year': '2015', 'journal-title': 'J Pharm Technol'}, { 'key': 'R56-20230812', 'doi-asserted-by': 'crossref', 'first-page': '429', 'DOI': '10.1016/j.jamda.2013.01.021', 'article-title': 'Use of proton pump inhibitors with lack of diagnostic indications in 22 ' 'Midwestern US skilled nursing facilities', 'volume': '14', 'author': 'Patterson Burdsall', 'year': '2013', 'journal-title': 'J Am Med Dir Assoc'}, { 'key': 'R57-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1940', 'DOI': '10.1111/j.1572-0241.2003.07665.x', 'article-title': 'Step-down from multiple- to single-dose proton pump inhibitors (PPIs): ' 'A prospective study of patients with heartburn or acid regurgitation ' 'completely relieved with PPIs', 'volume': '98', 'author': 'Inadomi', 'year': '2003', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'R58-20230812', 'doi-asserted-by': 'crossref', 'first-page': '1095', 'DOI': '10.1053/gast.2001.28649', 'article-title': 'Step-down management of gastroesophageal reflux disease', 'volume': '121', 'author': 'Inadomi', 'year': '2001', 'journal-title': 'Gastroenterology'}, { 'key': 'R59-20230812', 'doi-asserted-by': 'crossref', 'DOI': '10.1038/s41591-020-0916-2', 'article-title': 'Real-time tracking of self-reported symptoms to predict potential ' 'COVID-19', 'author': 'Menni', 'year': '2020', 'journal-title': 'Nat Med'}, { 'key': 'R61-20230812', 'doi-asserted-by': 'crossref', 'first-page': '452', 'DOI': '10.1002/jcph.825', 'article-title': 'Time trends in physician visits for gastroesophageal reflux disease ' 'before and after the Rx-to-OTC switch of proton pump inhibitors', 'volume': '57', 'author': 'Chang', 'year': '2017', 'journal-title': 'J Clin Pharmacol'}, { 'key': 'R63-20230812', 'doi-asserted-by': 'crossref', 'first-page': '458', 'DOI': '10.15585/mmwr.mm6915e3', 'article-title': 'Hospitalization rates and characteristics of patients hospitalized with ' 'laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, ' 'March 1–30, 2020', 'volume': '69', 'author': 'Garg', 'year': '2020', 'journal-title': 'MMWR Morb Mortal Wkly Rep'}, { 'key': 'R66-20230812', 'doi-asserted-by': 'crossref', 'first-page': '759', 'DOI': '10.15585/mmwr.mm6924e2', 'article-title': 'Coronavirus disease 2019 case surveillance - United States, January ' '22-May 30, 2020', 'volume': '69', 'author': 'Stokes', 'year': '2020', 'journal-title': 'MMWR Morb Mortal Wkly Rep'}], 'container-title': 'American Journal of Gastroenterology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://journals.lww.com/10.14309/ajg.0000000000000798', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 8, 12]], 'date-time': '2023-08-12T06:04:05Z', 'timestamp': 1691820245000}, 'score': 1, 'resource': {'primary': {'URL': 'https://journals.lww.com/10.14309/ajg.0000000000000798'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 8, 25]]}, 'references-count': 59, 'journal-issue': {'issue': '10', 'published-print': {'date-parts': [[2020]]}}, 'URL': 'http://dx.doi.org/10.14309/ajg.0000000000000798', 'relation': {}, 'ISSN': ['0002-9270', '1572-0241'], 'subject': [], 'container-title-short': 'Am J Gastroenterol', 'published': {'date-parts': [[2020, 8, 25]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit